Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia
文献类型：期刊论文
| 作者 | Liu, Xiaoli; Meng, Fanyi; Ma, Liyuan; Zhou, Guangbiao; Li, Juan; Chen, Zhu; Chen, Saijuan; Hu, Zheng; Liu, Jinglei; Pan, Xiaofen |
| 刊名 | BLOOD
 |
| 出版日期 | 2007 |
| 卷号 | 110期号:11页码:214B-214B |
| ISSN号 | 0006-4971 |
| 语种 | 英语 |
| 源URL | [http://ir.foo.ac.cn/handle/2SETSVCV/287]  |
| 专题 | 中国科学院广州生物医药与健康研究院 |
| 推荐引用方式 GB/T 7714 | Liu, Xiaoli,Meng, Fanyi,Ma, Liyuan,et al. Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia[J]. BLOOD,2007,110(11):214B-214B. |
| APA | Liu, Xiaoli.,Meng, Fanyi.,Ma, Liyuan.,Zhou, Guangbiao.,Li, Juan.,...&Pan, Xiaofen.(2007).Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia.BLOOD,110(11),214B-214B. |
| MLA | Liu, Xiaoli,et al."Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia".BLOOD 110.11(2007):214B-214B. |
入库方式： OAI收割
来源：广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。